All lobbying filings

MARSHALL & POPP, LLC

Lobbying for ELI LILLY AND COMPANY · Biopharmaceutical manufacturer.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Indiana · House · Senate · $60,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Medicare/Medicaid

Issues related to treatments for Alzheimers therapeutics.

Pharmacy

Issues related to prescription drug value, including H.R. 1, FY25 budget reconciliation, implementation of the Inflation Reduction Act (PL 117-169), and implementation of Executive Order 14273, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Issues related to FDA regulation of pharmaceuticals. Issues related to the 340B program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.